Glomerulonephritis, Membranoproliferative
"Glomerulonephritis, Membranoproliferative" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Chronic glomerulonephritis characterized histologically by proliferation of MESANGIAL CELLS, increase in the MESANGIAL EXTRACELLULAR MATRIX, and a thickening of the glomerular capillary walls. This may appear as a primary disorder or secondary to other diseases including infections and autoimmune disease SYSTEMIC LUPUS ERYTHEMATOSUS. Various subtypes are classified by their abnormal ultrastructures and immune deposits. Hypocomplementemia is a characteristic feature of all types of MPGN.
| Descriptor ID |
D015432
|
| MeSH Number(s) |
C12.777.419.570.363.615 C13.351.968.419.570.363.615 C20.425
|
| Concept/Terms |
Glomerulonephritis, Membranoproliferative- Glomerulonephritis, Membranoproliferative
- Glomerulonephritides, Membranoproliferative
- Membranoproliferative Glomerulonephritides
- Glomerulonephritis, Mesangiocapillary
- Glomerulonephritides, Mesangiocapillary
- Mesangiocapillary Glomerulonephritides
- MPGN
- Membranoproliferative Glomerulonephritis
- Mesangiocapillary Glomerulonephritis
- Glomerulonephritis, Hypocomplementemic
- Glomerulonephritides, Hypocomplementemic
- Hypocomplementemic Glomerulonephritides
- Hypocomplementemic Glomerulonephritis
Membranoproliferative Glomerulonephritis, Type I- Membranoproliferative Glomerulonephritis, Type I
- Subendothelial Membranoproliferative Glomerulonephritis
- Membranoproliferative Glomerulonephritis, Subendothelial
- Mesangiocapillary Glomerulonephritis, Type I
|
Below are MeSH descriptors whose meaning is more general than "Glomerulonephritis, Membranoproliferative".
Below are MeSH descriptors whose meaning is more specific than "Glomerulonephritis, Membranoproliferative".
This graph shows the total number of publications written about "Glomerulonephritis, Membranoproliferative" by people in this website by year, and whether "Glomerulonephritis, Membranoproliferative" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2004 | 2 | 0 | 2 |
| 2006 | 0 | 1 | 1 |
| 2007 | 1 | 0 | 1 |
| 2008 | 1 | 0 | 1 |
| 2010 | 1 | 0 | 1 |
| 2012 | 1 | 0 | 1 |
| 2022 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Glomerulonephritis, Membranoproliferative" by people in Profiles.
-
Severe acute kidney injury induced by crescentic glomerulonephritis in a child with infective endocarditis. Turk J Pediatr. 2022; 64(5):919-924.
-
DGKE variants cause a glomerular microangiopathy that mimics membranoproliferative GN. J Am Soc Nephrol. 2013 Feb; 24(3):377-84.
-
Abnormal immune complex processing and spontaneous glomerulonephritis in complement factor H-deficient mice with human complement receptor 1 on erythrocytes. J Immunol. 2010 Sep 15; 185(6):3759-67.
-
Pauci-immune and immune glomerular lesions in kidney transplants for systemic lupus erythematosus. Clin J Am Soc Nephrol. 2008 Sep; 3(5):1469-78.
-
New approaches to the treatment of dense deposit disease. J Am Soc Nephrol. 2007 Sep; 18(9):2447-56.
-
The simple design of complement factor H: Looks can be deceiving. Mol Immunol. 2007 Jan; 44(1-3):123-32.
-
Overexpression of complement inhibitor Crry does not prevent cryoglobulin-associated membranoproliferative glomerulonephritis. Kidney Int. 2004 Apr; 65(4):1214-23.
-
Selective expression of TGF-beta2 and TGF-beta3 isoforms in early mesangioproliferative glomerulonephritis. Nephron Exp Nephrol. 2004; 96(4):e111-8.
-
Autoantibody to complement neoantigens in membranoproliferative glomerulonephritis. J Pediatr. 1990 May; 116(5):S98-102.
-
A properdin dependent nephritic factor slowly activating C3, C5, and C9 in membranoproliferative glomerulonephritis, types I and III. Clin Immunol Immunopathol. 1989 Mar; 50(3):333-47.